Recurrent massive hemoperitoneum due to ovulation as a clinical sign in congenital afibrinogenemia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 90, Issue 2, 2011, Pages 192-194

  Cetinkaya, Serife Esra ^a   Pabuccu, Emre Goksan ^a   Ozmen, Batuhan ^a   Dokmeci, Fulya ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Afibrinogenemia; hemoperitoneum; ovulation

Indexed keywords

FRESH FROZEN PLASMA;

ABDOMINAL BLEEDING; ADULT; AFIBRINOGENEMIA; ANAMNESIS; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CONSERVATIVE TREATMENT; CORPUS LUTEUM; FEMALE; HEMOPERITONEUM; HUMAN; LABORATORY TEST; LAPAROTOMY; OVARIECTOMY; OVARY CYST; OVARY FUNCTION; OVULATION; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY;

AFIBRINOGENEMIA; FEMALE; HEMOPERITONEUM; HUMANS; OVULATION; RECURRENCE; YOUNG ADULT;

EID: 79951574283     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2010.01034.x     Document Type: Article

References (12)

1. Payne JH, Maclean RM, Hampton KK, Baxter AJ, Makris M,. Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill. Haemophilia. 2007; 13: 93-7. (Pubitemid 46002352)
2. Acharya SS, Dimichele DM,. Rare inherited disorders of fibrinogen. Haemophilia. 2008; 14: 1151-8.
3. Peyvandi F, Haertel S, Knaub S, Mannucci PM,. Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia. J Thromb Haemost. 2006; 4: 1634-7.
4. Schneider D, Bukovsky I, Kaufman S, Sadovsky G, Caspi E,. Severe ovarian hemorrhage in congenital afibrinogenemia. Acta Obstet Gynecol Scand. 1981; 60: 431. (Pubitemid 11018067)
5. Bottini E, Pareti FI, Mari D, Mannucci PM, Muggiasca ML, Conti M,. Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports. Haematologica. 1991; 76: 431-3.
6. Castaman G, Ruggeri M, Rodeghiero F,. Congenital afibrinogenemia: successful prevention of recurrent hemoperitoneum during ovulation by oral contraceptive. Am J Hematol. 1995; 49: 363-4.
7. Koussi A, Economou M, Athanasiou-Metaxa M,. Intra-abdominal haemorrhage due to a ruptured corpus luteum cyst in a girl with congenital afibrinogenemia. Eur J Pediatr. 2001; 160: 196-201.
8. Bogers JW, Huikeshoven FJ, Lotgering FK,. Complications of anticoagulant therapy in ovulatory women. Lancet. 1991; 337: 618-19.
9. De Moerloose, Neerman-Arbez M,. Congenital fibrinogen disorders. Semin Thromb Hemost. 2009; 35: 356-66.
10. Kobayashi T, Kanayama N, Tokunaga N, et al,. Prenatal and peripartum management of congenital afibrinogenemia. Br J Haematol. 2000; 109: 364-6. (Pubitemid 30350719)
11. Meschengieser SS, Alberto MF, Salviu J, Bermejo E, Lazzari A,. Recurrent haemoperitoneum in a mild von Willebrand's disease combined with a storage pool deficit. Blood Coagulation and Fibrinolysis. 2001; 12: 207-9. (Pubitemid 32525458)
12. Gomez A, Lucia JF, Perella M, Aguilar C,. Haemoperitoneum caused by haemorrhagic corpus luteum in a patient with type 3 von Willebrand's disease. Haemophilia. 1998; 4: 60-2. (Pubitemid 128501244)